Glucagon-like peptide-1 receptor (GLP-1) agonists are a class of medications that are mainly used to treat type 2 diabetes mellitus (T2DM) and, in some cases, for obesity management, but their role in type 1 DM is currently not well established [13]. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.